Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Discover Oncology is Scopus-indexed (Q3, CiteScore 1.9), WoS SCIE, DOAJ. Published by Springer Science and Business Media B.V..
Checked against the index lists dated .
ISSN 2730-6011Verify ISSN ↗
Publisher: Springer Science and Business Media B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 297 / 428 | 30th | Q3 |
| Endocrinology, Diabetes and Metabolism | 182 / 250 | 27th | Q3 |
| Endocrine and Autonomic Systems | 19 / 23 | 19th | Q4 |
| Cancer Research | 192 / 233 | 17th | Q4 |
| Endocrinology | 110 / 132 | 17th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q3, CiteScore 1.9.
Discover Oncology is Q3 in Oncology (rank 297 of 428), Q3 in Endocrinology, Diabetes and Metabolism (rank 182 of 250) and Q4 in Endocrine and Autonomic Systems (rank 19 of 23), by CiteScore 2025. It is ranked in 5 subject areas in all.
Discover Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.9, which places it in quartile Q3 at the 30th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.731, quartile Q2, with an H-index of 50.
The publisher lists an article processing charge of about US$1,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Discover Oncology is published by Springer Science and Business Media B.V. Its ISSN is 2730-6011.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Discover Oncology has an h-index of 35 and a 2-year mean of 2.34 citations per paper (OpenAlex). Its Scopus CiteScore is 1.9, quartile Q3. On 2-year citations it ranks #161 of 424 Scopus journals in Oncology.
Discover Oncology published 2,542 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 87 research articles (2026), authors are most often from China (75.3%), Iran (5%) and India (3.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 11 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.